CONDENSED CONSOLIDATED BALANCE SHEETS (USD $) In Thousands, unless otherwise specified	Jun. 30, 2013	Dec. 31, 2012
ASSETS
Cash and cash equivalents, $3,073 reserved at June 30, 2013	$ 8,123	$ 10,205
Other current assets	197	383
Total current assets	8,320	10,588
Patent license rights, net	902	980
Furniture and equipment, net	7	23
Total assets	9,229	11,591
LIABILITIES AND EQUITY
Accounts payable	74	233
Other accrued liabilities	27	61
Total current liabilities	101	294
Equity
Common Stock $.0005 par value; 100,000,000 shares authorized; 40,885,411 shares in 2013 and 2012 issued and outstanding	20	20
Additional paid-in capital	189,209	189,181
Accumulated deficit ($152,339 at June 30, 2013 and $150,335 at December 31, 2012, accumulated during development stage period)	(180,101)	(178,097)
Total Capstone Therapeutics Corp. stockholders' equity	9,128	11,104
Noncontrolling interest	0	193
Total equity	9,128	11,297
Total liabilities and equity	$ 9,229	$ 11,591